Renaissance Technologies - MEDICENNA THERAPEUTICS CORP ownership

MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 20 filers reported holding MEDICENNA THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MEDICENNA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$25
-43.2%
85,113
-5.8%
0.00%
Q2 2023$44
-53.7%
90,400
-39.9%
0.00%
Q1 2023$95
+17.3%
150,300
-14.9%
0.00%
Q4 2022$81
-99.8%
176,542
+288.9%
0.00%
Q3 2022$38,000
+2.7%
45,400
+41.4%
0.00%
Q2 2022$37,000
-27.5%
32,100
-19.1%
0.00%
Q1 2022$51,000
-68.3%
39,700
-59.9%
0.00%
Q4 2021$161,000
+387.9%
99,000
+731.9%
0.00%
Q3 2021$33,000
-66.3%
11,900
-63.3%
0.00%
Q2 2021$98,000
-82.9%
32,446
-77.0%
0.00%
-100.0%
Q1 2021$574,000
-5.6%
141,200
+8.2%
0.00%0.0%
Q4 2020$608,000
-35.7%
130,500
-43.2%
0.00%0.0%
Q3 2020$945,000229,9000.00%
Other shareholders
MEDICENNA THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,339,983$1,270,0440.60%
Worth Venture Partners, LLC 1,088,938$311,3270.18%
Sigma Planning Corp 634,550$187,1290.01%
Verition Fund Management LLC 555,392$158,7870.00%
Hudson Bay Capital Management LP 1,561,128$446,3260.00%
McKinley Carter Wealth Services, Inc. 79,259$23,3740.00%
Warberg Asset Management LLC 20,000$5,8980.00%
Patriot Financial Group Insurance Agency, LLC 15,000$4,4240.00%
LETKO, BROSSEAU & ASSOCIATES INC 120,000$35,3880.00%
Virtu Financial LLC 12,086$30.00%
View complete list of MEDICENNA THERAPEUTICS CORP shareholders